$PBIO Based on the Company's patented UST platform, the

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
130
$PBIO Based on the Company's patented UST platform, the BaroShear K45 is a unique breakthrough nanoemulsification system designed to resolve one of the most substantive problems facing manufacturers of biotherapeutic drugs, nutraceuticals (including hemp-derived CBD products), and other products containing oil-based active ingredients that are at best poorly soluble in water. As with any oil-based product, it is difficult for the water-based biochemistry of humans and other animals to access and absorb the active ingredients hidden within oil drops. Poor water solubility leads to lower absorption and bioavailability of active ingredients, which makes it particularly difficult to design and deliver proper dosing of the desired compound. More recently, growing science around nanoemulsion development has shown that oil-based active ingredients manufactured into high quality nanoemulsions have delivered dramatically increased absorption and bioavailability, resulting in higher quality finished products for the consumer.

Mr. Kenneth F. Micciche, PBI's Director of Marketing and Sales, commented: "We are elated to have achieved this pivotal milestone in production readiness in just three short years. Since the start of UST program in 2018, several note-worthy milestones have been achieved: from the development of the first prototype unit and its use in processing hemp-derived CBD Oil into highly stable and effective nanoemulsions; to the development of a larger scale, floor model "test bed" prototype used to generate important data on flow rates, particle sizes, novel valve designs, temperature controllers, material properties on performance and durability of system components; and finally to the determination of the final design specifications of the ready-to-sell system."

Mr. Micciche continued: "Our commercialization plan for the BaroShear K45 system is initially focused on the rapidly growing hemp-derived CBD market, which is projected to reach $20 billion by 2020. Three months ago, we announced that we had secured purchase orders for twelve (12) BaroShear K45 nanoemulsification systems. We plan to install these systems during the first half of 2021, which we believe will generate up to $3 million in revenue. Once these initial units are installed and in commercial use, we believe they will propel the close of multiple sales of additional BaroShear K45 systems during the latter half of 2021 and thereafter."

https://www.barchart.com/story/stocks/quotes/...evelopment
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Essity's Recent Share Buyback: What You Need to Know

Updated Category News Views 154

Essity's Commitment to Share Buybacks In recent developments, Essity Aktiebolag (publ) has embarked on a strategic journey involving the repurchase of Class B shares. From November 4 to November 8, 2024, the company successfully bought back a total of 270,000 of its own Class B shares. This initiative is part of a broader buyback program that aims to enhance shareholder...

Continue Reading
Michael Kalen Steers Eagle Rock Wealth for Big Growth

Updated Category News Views 6

Michael Kalen Takes Charge at Eagle Rock Wealth Now, here's a development that should make investors sit up and take notice: Michael Kalen has been named President of Eagle Rock Wealth, one of the big shots in private wealth management. With a history mired in leadership across major financial sectors, Kalen isn't your run-of-the-mill executive. His past gigs as President...

Continue Reading
Veris Residential's $3.4B Acquisition: Cashing In Big Time

Updated Category News Views 195

Veris Residential Seals the Deal A big shake-up in the multifamily REIT market—Veris Residential (NYSE:VRE) just got the green light for a whopping acquisition by Affinius Capital and pals, all to the tune of $3.4 billion in cash. Yep, you heard that right. Shareholders are looking at a sweet $19.00 per share coming their way. That's a hefty 23.2% premium over the...

Continue Reading
Kairon Labs and Solidus Labs Join Forces for Market Integrity

Updated Category News Views 281

Kairon Labs Partners with Solidus Labs to Innovate Market Practices Kairon Labs, a leading crypto market maker and liquidity provider, has entered into a strategic partnership with Solidus Labs, a pioneer in crypto-native compliance and risk management solutions. This collaboration is focused on enhancing Kairon Labs' compliance program in anticipation of the European...

Continue Reading
Investors Facing Class Action Lawsuits: Indivior, CrowdStrike, DXC, Five Below

Updated Category News Views 194

Update on Class Action Lawsuits Involving Major Stocks Investors, especially those holding shares in important companies, are currently facing a series of class action lawsuits. Renowned law firm Bragar Eagel & Squire, P.C. has announced the initiation of class actions against Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company...

Continue Reading